Cargando…
A novel tumor spheroid model identifies selective enhancement of radiation by an inhibitor of oxidative phosphorylation
There is a need for preclinical models that can enable identification of novel radiosensitizing drugs in clinically relevant high-throughput experiments. We used a new high-throughput compatible total cell kill spheroid assay to study the interaction between drugs and radiation in order to identify...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731106/ https://www.ncbi.nlm.nih.gov/pubmed/31523395 http://dx.doi.org/10.18632/oncotarget.27166 |